CH471829A - Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden - Google Patents

Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden

Info

Publication number
CH471829A
CH471829A CH5664A CH5664A CH471829A CH 471829 A CH471829 A CH 471829A CH 5664 A CH5664 A CH 5664A CH 5664 A CH5664 A CH 5664A CH 471829 A CH471829 A CH 471829A
Authority
CH
Switzerland
Prior art keywords
bisdehydrosteroids
hydroxy
preparation
Prior art date
Application number
CH5664A
Other languages
English (en)
Inventor
P Oliveto Eugene
Tanabe Masato
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US251747A external-priority patent/US3127430A/en
Priority claimed from US251744A external-priority patent/US3127428A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of CH471829A publication Critical patent/CH471829A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
    • A63F1/00—Card games
    • A63F1/06—Card games appurtenances
    • A63F1/18—Score computers; Miscellaneous indicators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Multimedia (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH5664A 1963-01-16 1964-01-07 Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden CH471829A (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US251747A US3127430A (en) 1963-01-16 1963-01-16 17alpha-methyl-1, 5-androstadienes-17beta-ol-3-one and derivatives thereof
US251744A US3127428A (en) 1963-01-16 1963-01-16 Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound
US263441A US3332967A (en) 1963-01-16 1963-03-07 3-hydroxy-1, 5-bis-dehydro steroids and methods for their manufacture

Publications (1)

Publication Number Publication Date
CH471829A true CH471829A (de) 1969-04-30

Family

ID=27400477

Family Applications (1)

Application Number Title Priority Date Filing Date
CH5664A CH471829A (de) 1963-01-16 1964-01-07 Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden

Country Status (9)

Country Link
US (1) US3332967A (de)
BE (1) BE642575A (de)
BR (1) BR6456127D0 (de)
CH (1) CH471829A (de)
DE (2) DE1493145B1 (de)
DK (1) DK121120B (de)
ES (1) ES295331A1 (de)
FR (2) FR4300M (de)
SE (1) SE321468B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4340538A (en) * 1980-07-21 1982-07-20 The Upjohn Company Process for producing 6α-fluoro-Δ1,4 -3-keto steroids
US4383947A (en) * 1981-07-24 1983-05-17 The Upjohn Company Introduction of a fluorine atom
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
EP1615944A4 (de) * 2003-04-01 2010-08-11 Harbor Biosciences Inc Antiandrogene mit marginaler agonistenwirkung und anwendungsverfahren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127430A (en) * 1963-01-16 1964-03-31 Schering Corp 17alpha-methyl-1, 5-androstadienes-17beta-ol-3-one and derivatives thereof
US3127428A (en) * 1963-01-16 1964-03-31 Schering Corp Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound

Also Published As

Publication number Publication date
DK121120B (da) 1971-09-13
US3332967A (en) 1967-07-25
BR6456127D0 (pt) 1973-07-17
DE1793618C3 (de) 1975-10-23
DE1793618B2 (de) 1975-03-06
FR1602256A (en) 1970-11-02
ES295331A1 (es) 1964-06-01
SE321468B (de) 1970-03-09
DE1493145B1 (de) 1971-11-25
BE642575A (de)
DE1793618A1 (de) 1972-02-03
FR4300M (de) 1966-07-25

Similar Documents

Publication Publication Date Title
CH463787A (de) Verfahren zur Herstellung von Polyiminolactonen
CH444868A (de) Verfahren zur Herstellung von Fluoracylaziridinen
CH466300A (de) Verfahren zur Herstellung von Dihydrotriazinen
CH449623A (de) Verfahren zur Herstellung von 4-Alkyl-5-cyan-oxazolen
CH438286A (de) Verfahren zur Herstellung von Dibenzocycloheptadien-ketoxim-O-äthern
CH457432A (de) Verfahren zur Herstellung von 2-Hydroxyäthyl-6,8-didesoxy-6-(1-methyl-4-propyl-pyrrolidin-carboxamido)-7-O-methyl-1-thio-D-erythro-D-galacto-octopyranosid
CH458329A (de) Verfahren zur Herstellung von 2-Alkylcyclopentan-1,3-dionen
AT244338B (de) Verfahren zur Herstellung von 3-Amino-isoxazolen
CH440240A (de) Verfahren zur Herstellung von Fluorjodalkanen
CH466272A (de) Verfahren zur Herstellung von Cycloalkylmethylaminobenzophenonen
CH471829A (de) Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden
CH449610A (de) Verfahren zur Herstellung von Oestra-4,9-dien-3-olen
CH426836A (de) Verfahren zur Herstellung von Naphthindolizinchinonen
CH456579A (de) Verfahren zur Herstellung von Diphenylbenzocycloalkenen
CH430716A (de) Verfahren zur Herstellung von trans-2-Phenyl-3-methylmorpholin
CH450378A (de) Verfahren zur Herstellung von B-Hydroxyäthylthiocelestosaminid
CH459973A (de) Verfahren zur Herstellung von Acetylacetamiden
CH416106A (de) Verfahren zur Herstellung von Polydodecalactam
CH447211A (de) Verfahren zur Herstellung von Diaminodihydroxy-anthrachinonen
CH432536A (de) Verfahren zur Herstellung von Diamino-monoazidotriazinen
CH425809A (de) Verfahren zur Herstellung von Pyridazoniminen
AT266336B (de) Verfahren zur Herstellung von 3-Keto-4,6-bisdehydro-9-β,10α-steroiden
CH472397A (de) Verfahren zur Herstellung von 6-Halogen-1a,2a-methylen-16a-methyl- 4,6-pregnadien-17-ol-3,20-dionen
CH424793A (de) Verfahren zur Herstellung von 4-Nitro-5-hydroxy-pyridazonen-6
CH442340A (de) Verfahren zur Herstellung von Aminoalkyl-1-naphthylacetamiden

Legal Events

Date Code Title Description
PL Patent ceased